Haptoglobin Phenotype and Smoking: Effects on Iron Levels in Parkinson’s Disease

Status:

Recruiting

Study area:

Neurology

Principal investigator:

Paola Costa-Mallen, PhD

Co-investigator(s):

Yoshimi Anzai, MD, MPH; Harvey Checkoway, PhD; Shu-Ching Hu, MD

Project period:

02/01/2013- 01/31/2015

NIH/National Institute of Neurological Disorders and Stroke

The purpose of this project is to study the alterations in iron metabolism present in patients with Parkinson’s disease as compared to healthy subjects, and the effect of lifestyle habits such as smoking and diet, or genetic traits such as haptoglobin phenotype, on iron levels. The study is recruiting both patients with PD (recently diagnosed) and healthy participants without PD (healthy participants of age 58-82 years old).

To Participate:
If you are interested in participating in the study or for more information,
please call the haptoglobin and iron study line at 425-602-3316.

You are here

Haptoglobin Phenotype and Smoking: Effects on Iron Levels in Parkinson’s Disease